Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
First Hawaiian Financial Corporation announced an all-stock acquisition of TriCo Bancshares that will give TriCo shareholders 2.095 First Hawaiian shares per TriCo share, implying $63.12 per TriCo share based on First Hawaiian's July 10, 2026 close. The transaction trims First Hawaiian's share price in early trading while lifting TriCo stock. If co…
Applied Digital is executing an aggressive AI and HPC data-center buildout that just turned a visible corner: Phase 1 Building 2 at Polaris Forge 1 delivered 75 MW on-time, bringing live campus capacity to 175 MW and a contracted pipeline to 400 MW. The business is capital intensive and currently priced for perfection — valuation metrics are rich a…
Asian Paints has implemented an around 12% across-the-board price increase, the company said, pointing to higher raw material costs tied to recent tensions in West Asia. The manufacturer warned that input prices may take time to normalize and characterized the rise as the steepest in India’s paint sector. Peer firms have also lifted prices this yea…
Biohaven (BHVN) has meaningful near-term clinical catalysts and improving investor interest, but the company carries a history of late-stage setbacks and material cash burn. This idea is a tactical long sized for a swing trade: entry at $15.50, target $22.00, stop loss $12.00, horizon mid term (45 trading days).
Clearmind Medicine Inc. reported positive early insights from its ongoing Phase I/IIa clinical trial of CMND-100, a non-hallucinogenic MEAI compound targeting Alcohol Use Disorder (AUD). Investigators from Yale and Johns Hopkins highlighted a favorable safety profile, good recruitment despite strict criteria, and the potential for an accessible tre…
JPMorgan raised American Express to Overweight in its consumer finance preview, even as the firm signaled broad caution across the sector. The bank cautioned that renewed U.S.-Iran hostilities, a cooling labor market and a hawkish rates backdrop - with mortgage rates near 6.5% - could depress consumer and refinance activity. JPMorgan left other con…
Compass Minerals (CMP) looks inexpensive on operational multiples and free cash flow despite recent noise from weather, accounting and derivative litigation. With EV/EBITDA around 8.4, free cash flow of roughly $100M and a market cap near $1.25B, I think the market is discounting a durable recovery. This trade targets a rebound toward $36 over the …
Dongfeng Motor Corp. will present electric vehicle models at a Montreal event as it prepares to seek Canadian regulatory certification and possible future sales under a temporary low-tariff quota negotiated by Prime Minister Mark Carney. The move follows the removal of a 100% surtax on up to 49,000 Chinese-made EVs for an initial one-year period, a…
Pulsenmore Ltd. (NASDAQ:PLSM) saw its share price rise about 160% after the company was selected to join Israel’s Healthcare AI Regulatory Sandbox Program, an initiative run by the Israel Innovation Authority and the Ministry of Health. The selection includes funding as part of a project valued at $1 million and will support development and clinica…
Banzai International, Inc., a marketing technology company, has priced an underwritten public offering of 327,273 shares of Class A common stock at $2.75 per share, raising approximately $0.9 million gross proceeds. The funds are intended for working capital and general corporate purposes. The offering is expected to close around July 14, 2026, wit…
Safe Pro Group Inc., a Nasdaq-listed company specializing in AI-enabled defense and security solutions, has been awarded a Small Business Innovation Research (SBIR) contract by AFWERX, the innovation arm of the U.S. Air Force. The contract focuses on developing an AI dataset using images of Foreign Object Debris/Damage encountered in Air Force and …
Truist Securities upgraded Biogen from Hold to Buy and increased its price target to $235 from $190, highlighting confidence in the company’s Alzheimer’s and immunology pipeline ahead of several pivotal data readouts over the next two years. The firm emphasized forthcoming detailed Phase 2 data for anti-tau candidate diranersen (BIIB080) at AAIC on…
Voyager Therapeutics announced positive six-month GLP toxicology study results for VY1706, their investigational gene therapy targeting tau protein in Alzheimer's disease. The therapy showed good tolerability and up to 75% sustained tau reduction in key brain regions of non-human primates following a single intravenous dose. With FDA IND clearance …
MKS Inc., a provider of enabling technologies for semiconductor manufacturing and specialty industrial applications, announced it will release its second quarter 2026 financial results after market close on August 5, 2026, followed by a conference call with management on August 6.
Malibu Boats, Inc. has successfully refinanced its credit facility, replacing the prior agreement with Truist Bank. The new financing structure introduces a $100 million term loan alongside a $250 million revolving credit facility, extending the maturity date from 2027 to 2031. This strategic move enhances the company's financial flexibility to inv…
Immutep Limited reported mature overall survival data from its INSIGHT-003 Phase I trial involving eftilagimod alfa combined with pembrolizumab and chemotherapy in first-line non-squamous NSCLC patients. The median overall survival reached 30.9 months, outperforming historical benchmarks, particularly benefiting patients with low PD-L1 expression. …
Sana Biotechnology announced publication in The New England Journal of Medicine of a peer-reviewed letter detailing 14-month follow-up data from a study of its hypoimmune (HIP)-modified pancreatic islet cell therapy. The data demonstrate safety, immune evasion, and durable insulin production without immunosuppression in type 1 diabetes patients. Sa…
Enlivex Ltd. announced that the FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to Allocetra™, its clinical-stage immunotherapy for treating age-related primary knee osteoarthritis in patients aged 64 and older. This designation enables early FDA engagement, potential accelerated approval, and priority review, supporting faste…
Tactile Systems Technology has entered into an exclusive agreement to distribute ElastiMed's MyoSleeve, a wearable compression device for chronic swelling, across U.S. Department of Veterans Affairs and Department of Defense patients. The MyoSleeve offers a discreet, cable-free therapy option suitable for earlier stages of chronic swelling, complem…
Alarum Technologies Ltd. announced ongoing investigations into disruptions affecting its subsidiary NetNut Ltd.'s proxy network operations. The company has engaged external cybersecurity and forensic experts to determine the root cause. Concurrently, it is implementing an operational efficiency plan involving significant workforce reductions and un…
Madrigal Pharmaceuticals announced that the USPTO has issued three new patents for their drug Rezdiffra (resmetirom), which is used to treat metabolic dysfunction-associated steatohepatitis (MASH). Two patents strengthen protection for moderate fibrosis stages (F2/F3), while a third patent covers treatment for well-compensated cirrhosis (F4c). Thes…
Enviri Corporation, a global provider of environmental and operational solutions to the metal and rail industries, announced it will release its second quarter 2026 earnings results on August 11 before NYSE open. The company will host a live conference call and webcast at 9:00 am ET that day for investors and financial analysts. Enviri operates in …
Apollomics Inc., a clinical-stage biopharmaceutical company focusing on oncology therapies, announced it has regained compliance with Nasdaq's Market Value of Listed Securities requirement, resolving prior concerns over its market capitalization falling below the minimum $35 million threshold. This reinstatement secures its listing on the Nasdaq Ca…
Circle8 Group, Inc. has successfully extended two major public sector contracts in the Netherlands, with a combined annual value of approximately $20 million. These contract renewals with Waternet and De Bevelanden strengthen Circle8's recurring revenue and underscore its robust commercial momentum in 2026, following multiple other sizable contract…
Geron Corporation, a commercial-stage biopharmaceutical company focused on blood cancer treatments, announced the appointment of Chinmaya Rath as Chief Business Officer. With over 25 years of industry experience, Rath is expected to strengthen Geron's strategic initiatives and drive the global commercialization of their telomerase inhibitor product…
